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Summary.-Silica specifically kills macrophages in vitro, and in vivo has been used
as a method of determining the possible immunological or other roles of macro-
phages in a number of viral infections. In experiments reported here, injection of 30
or 50 mg silica i.p. increased the severity of the oncogenic effects of the murine
sarcoma virus (MSV) and Friend virus (FV) in BALB/c mice. Unlike Herpes simplex
and Coxsackie B-3 infections, however, passive transfer of adult macrophages to
suckling mice did not protect the latter against MSV. In mice injected with silica,
histological evidence of the compensatory proliferation of macrophages suggests
that precursors of these cells may act as target cells for the virus and that this may
override any immunosuppressive response effected by the silica. In addition, there
was a considerable enhancing effect on the erythroproliferative response to both
MSV and FV by injection of saline 5 h before the virus, and indeed to FV after only a
simple abdominal needle puncture. We attributed this to the lymphopenic immuno-
depressive effects of stress, and our data may explain previously published findings
of augmented oncogenic responses in mice after "normal" serum injections.
Newborn BALB/c (FV-lb) mice were susceptible to N-tropic FV, but developed
resistance by 29 days of age. Antithymocyte serum (ATS) but not silica injections or
adult thymectomy ablated this resistance. C57BL (FV-2r) mice were completely
resistant to FV; however, those receiving FV and ATS developed late-onset leukaemia
histologically characteristic of that produced by the helper component of the FV
complex.
SILICA, administered i.p. or i.v., has
been shown to exert a variety ofinfluences
on the immune system of the mouse,
believed in some part to act via specific
macrophage killing, which is readily
demonstrable in vitro (Kessel et al., 1963;
Allison et al., 1966; Levy & Wheelock,
1975). Some viral infections (e.g. Herpes
simplex and Coxsackie B-3) cause severe
effects in, and may be lethal to, suckling
mice, whereas adults are resistant. The
passive transfer of macrophages from
adult mice protects susceptible sucklings,
whilst conversely the resistance of adults
is reduced or ablated by prior treatment
with silica (Hirsch et al., 1970; Rager-
Zisman & Allison, 1973; Zisman et al.,
1970). Both these situations indicate a
contributory role for the macrophage in
immune protection against viral infec-
tions. However, the factors are complex
in vivo, since macrophage damage by
silica actually stimulates proliferation and
migration ofnew macrophage populations.
Some enhanced viral effects may be due,
therefore, not solely to immunosuppres-
sion mediated by the killing of macro-
phages, but to increased viral replication
in and distribution by this new population
(du Buy, 1975).
We were interested to know whether
the killing of macrophages in vivo by
silica would alter the response to murine
oncogenic viral infections. In particular,
the murine sarcoma virus (MSV) (Harvey,
1964) loses most of its oncogenic potential
in adult mice, and we tested whether
treatment by silica before MSV had an578 J. J. HARVEY, B. RAGER-ZISMAN, E. F. WHEELOCK AND P. A. NEVIN
enhancing effect, and whether transfer of
adult macrophages would protect suckling
mice. The erythroproliferative disease
caused by Friend virus (FV) (Friend, 1957)
is enhanced by prior treatment of adult
mice with silica (Larson et al., 1972) but
passive transfer of macrophages may or
may not protect (Marcelletti & Furmanski,
1978; Ceglowski & Friedman, 1975). How-
ever, unlike MSV, both suckling and adult
mice are susceptible to FV.
In parallel with experiments in which
we looked at the effect of silica on MSV
and FV infections, we used DBA2 and
BALB/c strains of mice, which have the
same H2 complex and with the exception
of the FV-1 locus (Lilly, 1970) similar
genes controlling murine leukaemia virus
(MuLV) infections, to explore the possi-
bility that treatments such as silica, ATS
or thymectomy might influence FV-1l
control in vivo.
METHODS AND MATERIALS
Animals.-BALB/c mice were bred at the
Clinical Research Centre; DBA2 and C57BL
strains were obtained from OLAC Ltd, Shaw's
Farm, Bicester.
Viruses. The origin of the Harvey strain
of MSV has been described (Harvey, 1964).
The virus used in these experiments was
maintained by filtrate passage in BALB/c
rnice, and titrated by focus formation on
mouse embryo fibroblasts (Hartley & Rowe,
1966).
Twvo strains of Friend virus were used, an
"N-tropic" strain (FV-N) (Hartley et al.,
1970) was maintained by filtrate passage in
DBA2 (N-type) mice. As expected, BALB/c
(B-type) adult mice were resistant to FV-N
(Pincus et al., 1971). An "NB-tropic" strain
(FV-NB), originally obtained from Dr C.
Friend, was maintained by filtrate passage in
BALB/c mice (the DBA2 strain was also
susceptible). FV-N and FV-NB were titrated
in vivo using the spleen-weight assay (Rowe
& Brodsky, 1959).
Silica. Silica, in the form of quartz dust
(average particle size 5 jum), was obtained
from Dowson & Dobson Ltd. Just before
use, autoclaved dust was suspended in
phosphate-buffered saline (PBS), or in Eagle's
minimal essential medium (MEM) and ex-
posed briefly to ultrasonic vibration.
Macrophages.-Peritoneal macrophages,
washed from the abdominal cavities of adult
mice with PBS at pH 7-1, were separated
from other peritoneal cells by their adherence
to plastic. "Stimulated" macrophages were
prepared by inoculating mice i.p. with 2 ml
of a 10% protease peptone solution 72 h
before removing cells as described above.
Antithymocyte serum (ATS).-Thymuses
from 6-8-week-old mice were gently pressed
through a stainless-steel mesh. The resultant
cell suspension was incubated at 37°C to
remove adherent macrophages, washed twice
and then passed through sterile cotton wool.
Rabbits were injected i.v. twice with 108-109
viable cells with a 10-day interval. Serum
collected 10 days after the second immuniza-
tion was absorbed twice for 1 h at room
temperature with fresh, washed, mouse red
blood cells (1:1) and then with cultured
macrophages for a further hour. Serum was
filtered through a 0 45 tum Millipore Swinnex
filter before storage. Activity was measured
in vivo by the retention by CBA mice of A-
strain skin grafts for longer than 3 weeks.
Adrenalectomy. Eight-week-old BALB/c
mice, anaesthetized by Nembutal, were
adrenalectomized according to the protocol
of Castro (1974). Operated animals were then
given a 1: 1 saline/dextrose mixture to drink.
Thymectomy. Thymus lobes were removed
from 5-week-old mice anaesthetized with
Nembutal, by aspiration with a water-jet
vacuunm pump via a midline anterior-medi-
astinalapproach. Atnecropsy,thymectomized
animals were screened histologically for
evidence of any remaining thymic tissue.
Histology.-Tissues were fixed in formol-
acetic alcohol and stained with haematoxylin
and eosin. Organ imprints and blood smears
were stained with May-Griinwald Giemsa.
RESULTS
Effect of silica on the oncogenicity of MS V
The first group of experiments was de-
signed to see whether prior injection of
silica suspension into BALB/c mice en-
hanced their response to MSV (Table I).
A 30-mg silica suspension in MEM was
injected i.p. into 4-week-old BALB/c
mice, followed 24 h later by virus (104-5
FFU/ml). We injected either 0X2 ml i.p. orRESPONSES TO ONCOGENIC VIRUSES
TABLE I.- Enhancing effect of 30 mg i.p. silica on MSV infection in 4-week-old
BALBIc mice*
Doset
and route
Treatment of MSV
AISV 0-2 i.p.
0-1 i.p.
+0-1 i.m.
Silica 0 2 i.p.
+
A.ISV 0-1I i.p.
+0-1 Im.M
Silica
None
No.
and sex
injected
10
(5r, 5y)
10
(6,, 4?)
9
(3d, 6Y)
8
(3cr, 5Y)
10
(53, 5y)
20
(10&, 109)
Mean
spleen wt
(mg)
(and range)
386
(120-1022)
208
(144-351)
837
(632-1284)
775
(280-1073)
356
(169-533)
138
(102-200)
Mean
% PCV
(and range)
43
(39-49)
43
(32-49)
26
(13-48)
31
(24-39)
42
(39-44)
46
(43-49)
No. with other MSV effects
_t- - ____
Brain Peritoneal
haemorrhages Effusionst tumours
0 0 0
0
4
0
0
0 0
6 3
6 2
0 0
* All injected mice killed 16 days later, when 46 days old; uninjected mice at 43 days o0(l.
t All at i04.5 FFU/ml.
+ Pleural and/or peritoneal.
the same dose divided between two
routes, 041 ml i.p. and 041 ml i.m. into the
thigh muscle. Sixteen days later the
animals were killed, spleens were weighed
and blood packed-cell volumes were meas-
ured in addition to the routine histology
of affected tissues. The mice were com-
pared with untreated controls, and others
injected with MSV or silica only.
Mice injected with silica alone had
obviously enlarged spleens, livers, mesen-
teric and parathymic lymph nodes, accom-
panied by massive mesenteric adhesions
to the gut, liver, and peritoneal and
diaphragm walls. Spleen weights were in
some cases increased to 4 x normal, and
histology showed that this was due mainly
to accumulations of macrophages; follicles
were also enlarged and disorganized and
cell debris common. Evidence ofincreased
haemopoiesis, fibrosis of the splenic cap-
sule and considerable numbers of poly-
morphs were other variable features. No
tumours were present.
Mice injected solely with MSV showed
characteristic pathological effects, namely,
splenomegaly due to erythroblastic pro-
liferation, depressed blood packed-cell
volumes, and one animal had a small
sarcoma of the diaphragm wall. It should
be noted that no mice developed tumours
of the thigh; the age of the mice and dose
40
of MSV were deliberately chosen to give
only slight effects, since we were interested
in possible enhancement by silica. As
described in earlier reports (Harvey &
East, 1971) the route of injection affected
the pattern of response; mice injected i.p.
had greater splenomegaly than those in-
jected with the same dose divided between
the i.p. and i.m. routes.
As can be seen in Table I, silica pre-
treatment drastically enhanced the patho-
logical effects of MSV; spleen weights
were greater, blood packed-cell volumes
lower and, in contrast to those injected
with either virus or silica alone, the
majority (12/17) had massive pleural
effusions, which in some cases were
accompanied by pin-point brain haemor-
rhages (Figure). Pleural effusions, typically
induced by high-titre MSV (Harvey strain)
are rapidly lethal (Harvey & East, 1971);
indeed, this determined the date the ex-
periment was terminated, since only the
mice in this group were dying. As in those
mice injected with silica alone, the route
of injection still exerted a clear effect on
the resultant pathology. In the silica-
pretreated group there were also more
diaphragm and peritoneal tumours charac-
teristic of i.p. MSV infection. Indeed, the
number counted in this group may not
reflect the true extent of the increase,
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FIG.-Meningeal haemorrhage lying adjacent to the cerebellum of a BALB/c mouse injected with
MSV and silica. Inflammatory cells are present within the liaemorrhage. x 105.
since it was difficult to see small tumours
because of the widespread adhesions
caused by silica. It was interesting that
enhancement, while obvious, was not such
that tumours arose at the site of i.m. in-
jection, although many mice were ex-
tremely sick when killed only 16 days
after injection. Spleens were enlarged in
the groups injected with silica or MSV
only, but the effect of combined treatment
was more than additive, particularly in
those injected with virus divided between
two routes. However, in this dually
treated group the histological appearance
was generally that of a response to higher
titre MSV (i.e. much increased haemo-
poeisis) rather than an equal mixture of
this effect and obvious macrophage in-
filtration. If the enhancement of MSV by
silica was mediated via a depression of the
immune response caused by the killing of
macrophages, then it was possible, as has
been shown for other viral infections
(Hirsch et al., 1970; Rager-Zisman &
Allison, 1973) that adult macrophages
could exert a protective effect against
MSV in suckling mice.
Failure of transferred adult peritoneal
macrophages toprotect suckling mice against
MSV
Either 2 x 1.07 stimulated or unstimu-
lated adult BALB/c macrophages sus-
pended in 0O1 ml MEM, or 0-1 ml MEM
alone, were injected i.p. into 11-12-day-
old BALB/c mice 5 h before MSV. Con-
trols were age-matched untreated mice,
and those receiving virus or macrophages
only. Mice in most affected groups rapidly
became sick, and all were killed 13
days after infection. Table II shows that
neither stimtilated nor unstimulated adult
BALB/c macrophages protected suckling
BALB/c mice from the effects of MSV;
indeed, on the contrary, the effects were
enhanced. Spleen weights and tumour
sizes at the site of i.m. injection were
greater, an(I anaemia more severe. ItRESPONSES TO ONCOGENIC VIRUSES
TABLE II.-Enhancing effect on MSV of 2 x 10 adultperitonealmacrophages injected i.p.
into suckling (11-12 days old)BALB/c mice* 5 h before virus
No. of tumours
r,
Treatment
MSVt
Macrophages
+MSV
"Stimulated"
macrophages
+MSV
MEM+MSV
Stimulated
macrophages
None
(28 days old)
No. and sex
injected
23
(12,, Ily)
15
(8d, 7y)
14
(18T, 6$)
9
(5&, 4y)
4
(2,3, 2y)
20
(1O&, 10y)
Spleen
wt (mg)
184
(114-270)
307
(145-609)
317
(186-518)
235
(147-459)
109
(100-121)
126
(99-161)
% PCV
39
(37-45)
36
(22-41)
32
(21-38)
l.p.
21
28
29
405
(30-49)
ND
Diaphragm
and Diam. of
splenic i.m. tumour
mesentery (mm)
9 5.9
(5-5-7*5)
21 7.9
(5 5-11)
18 9.5
(4-5-12)
ND ND
42
(35-50)
* All mice killed 13 days after infection (24 days old).
I Titre = 104-5 FFU/ml, dose =0 1 ml i.p. +0-05 ml i.m. (thigh).
should be noted that at the age that the
mice were killed (24 days) a leg width of
9 mm represents gross enlargement. There
were more tumours in the splenic mesen-
tery and diaphragm of macrophage-
pretreated groups than in the controls,
although no clear difference was seen in
the numbers disseminated at other sites
throughout the peritoneum. There was
also some evidence of enhancement of
MSV in the group preinjected with MEM
only, although in this case data on thigh
tumour sizes were not obtained. No mice
developed pleural or peritoneal effusions
or brain haemorrhages.
Enhancing effects ofsilica and stress onFV
infection
In parallel with these experiments, we
confirmed an earlier report (Larson et al.,
1972) that silica pretreatment enhances
the effects of Friend virus, which is onco-
genic in both adult and suckling mice.
Thirty or 50 mg silica suspended in 0 5 ml
MEM, or 0 5 ml MEM alone, were injected
i.p. into adult female BALB/c mice,
followed 5 h later by 0 I ml FV-NB. Con-
trol groups were injected with silica or
virus alone. Spleen weights were obtained
19 days later. Typical erythroblastic
splenomegaly occurred in the mice in-
jected with FV only. 50 mg silica only
caused the same widespread effects de-
scribed in weanlings in the previous ex-
periment, whereas those in mice injected
with 30 mg were far less severe. Table III
shows a clear dose-response relationship
between silica and spleen weights. Both 30
and 50 mg silica enhanced the erythro-
blastic effect of FV, and augmentation of
TABLE III.-Enhancing effect of silica
injected i.p. on FV-NB infection in
adultBALBIcfemale mice*
No.
Treatment injected
FVt 8
Silica (50 mg)
Silica (50 mg)
+FV
Silica (30 mg)
Silica (30 mg)
+FV
MEM+FV
None
Spleen wt
(mg)
437
(134-1206)
5 555
(515-599)
5 2277
(2197-2902)
6 370
(329-407)
5 1962
(476-3613)
5 1199
(647-1981)
10 120
(101-138)
* All killed 19 days after injection.
t Dose = 103 ID5o/mouse.
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spleen weights in groups receiving both
virus and silica was more than the sum of
that caused by either the virus, or respec-
tive doses of silica alone.
Although there had been an indication
that pre-treatment with MEM had slightly
enhanced the response to MSV (Table II)
we were surprised to find how greatly it
affected the FV-infected mice. This ex-
periment (Table III) was therefore re-
peated using PBS or MEM, both of which
had been used as suspending media for
TABLE V. Enhancement of FV-NB
induced splenomegaly in 8-week-old
BALB/cmale micet byprior i.p. injection
of 02 ml PBS, and by simple abdominal
needle puncture
Treatment,
FV*
PBS +FV (5 h later)
Abdominal needle
puncture + FV
(5 h later)
No. AMean spleen
injecte(l wt (mg)
9 739
(411-237)
10 1217
(826-1622)
1154
10 (409-1964)
FV
PB
PB
PB
TABLE IV.-Enhancement of FV-NB
induced splenomegaly in 20-week-old
BALB/c micet by prior i.p. injection of
0-2 ml PBS or MEM
No. andl sex Mean spleen
Treatment irnjected wt (mg)
T* 12 477
(6cD, 62) (215-704)
3S orMEM 12 1180
+FV (5 h later) (6J, 6I) (424-2300)
3S or MEM 16 783
+AFV (18 h later) (8,, 8y) (211-1891)
S or MEMI 12 158
(6d, 6y) (129-202)
* Dose=102.5ID5W/mouse.
t All killecl 21 days after injection.
silica in earlier experiments (Table IV).
Both 5h and 18h intervals between injec-
tions were tested. There was, again,
enhancement of erythroblastic spleno-
megaly in animals pretreated with saline
or MEM, and this was greater when in-
jections were 5 rather than 18 h apart. It
seemed possible that MEM or PBS con-
tained factors which stimulated produc-
tion oftarget cells for the virus. In further
experiments, therefore, we included
"sham-injected" groups which received an
abdominal needle puncture but no fluid.
Again (Table V), spleen weights in pre-
treated animals were greater, whether or
not fluid had been injected before the
virus.
Thus it became clear that some enhance-
ment might be due to stress-possibly via
an effect on the immune system by adrenal
corticosteroid hormone. Adrenalectomized
and intact female mice (1 0 per group)
* Dose=103JD50/mouse.
t All killed 21 (lays after injection.
were therefore given FV, but showed com-
parable spleen weights 3 weeks later
(means of 873 and 872 mg respectively)
although the former were slightly more
anaemic. Unexpectedly, saline pretreat-
ment did not obviouslyenhance the splenic
response to FV, in either adrenalectomized
or intact mice (mean weights 906 and 995
mg respectively), so no conclusions could
be drawn regarding any stress effect
mediated by adrenal corticosteroid hor-
mone. In these experiments, all the
animals, including relevant controls, had
been held in the same animal room for
several weeks before injection, whereas
previously mice had been removed from
the relatively quiet SPF breeding unit to
the experimental rooms just before use.
It was possible that the more "settled"
animals had not been stressed by the
injection procedure. Nevertheless, when
we then compared mice reared in the
experimental animal laboratory with
others bred and recently transferred from
the SPF unit, pretreatment of whatever
kind 5 h before FV again had an enhancing
effect on the virus (Table VI). This in-
cluded animals simply taken out of their
cages and immediately replaced. Whilst
enhancement was particularly evident in
the SPF males, those conventionally
reared were more variable in response.
The same trend occurred in female mice,
but spleen weights were too variable for a
clear conclusion to be reached.RESPONSES TO ONCOGENIC VIRUSES
TABLE VI.-Comparison ofresponse to "stress" on FV-NB-infection in specific pathogen
free (SPF) and conventionally reared (CR) BALB/c mice*
Male
Mean spleen wt (mg)
Treatment
FVt
PBS+FV (5 h later)
"Sham" injection+FV (5 h later)
"Handling" +FV (5 h later)
PBS
SPF
488
(212-792)
853
(418-1379)
876
(456-1543)
764
(202-1156)
125
(114-143)
* All killed 20 days after injection.
t Dose=103ID5o/mouse.
5 mice per group, except groups markedt (6).
Factors affecting the resistance ofmice toFV
Concurrently we examined the resist-
ance of BALB/c ("B-type") mice to a
strain of N-tropic FV which is lethal in
adult DBA/2 ("N-type") mice. The re-
sistance of BALB/c mice to N-tropic FV
is age-dependent. All 24 mice tested were
susceptible to 104 ID50, if injected when
they were 6 days old or less. By 11 days,
although most(7/8)stilldevelopederythro-
blastic splenomegaly, latent periods had
increased, and one individual remained
healthy for the duration ofthe experiment
(38 weeks). An increasing number (13/22)
were resistant when injected at 14-21
days, and by 29 days resistance was com-
plete. Since, therefore, resistance to FV
determined by the FV-1 locus is not
absolute in vivo, we tested whether it
could be abrogated in adult mice by
various treatments affecting the immune
response such as silica, ATS and/or
thymectomy.
Resistance of BALB/c adults to FV-N
was not affected by injecting 50 mg silica
5 h before the virus, nor by adult
thymectomy. By contrast, ATS com-
pletely abrogated the resistance of either
adult intact or thymectomized BALB/c
mice to N-tropic FV; all recipients of FV
and ATS treatment rapidly developed
erythroblastic splenomegaly (Table VII).
To investigate further the effect ofATS
A
CR
692
(327-920)
850
(416-1150)
1017t
(272-2211)
479t
(343-791)
145
(129-166)
Female
Mean spleen wt (mg)
SPF CR
1460 1473
(535-2114) (207-2407)
1223 1844
(562-1780) (1534-2419)
1822 2079
(844-2657) (1244-2798)
1716 1608
(427-2586) (706-2625)
129 150
(123-144) (125-192)
TABLE VII.-Ablation by ATS treatment of
the resistance of adult female BALB/c
mice to N-tropic FV
Treatment
FV-N*
FV-N
+ATS$
FV-N
+TX§
FV-N
+ATS+TX
Latent No. with Mean
period EBSt/No. spleen
(days) injected wt (mg)
107 0/6 133
(109-149)
26 8/8 1560
(460-2125)
180 0/7 174
(132-297)
25 8/8 1750
(920-2452)
* Dose = 104ID5o/mouse.
t EBS=erythroblastic splenomegaly.
t Starting when mice were 8 weeks old, 5 con-
secutive daily injections of ATS, the 4th coincident
with FV.
§ Thymectomy at 5 weeks.
treatment, C57BL mice were tested.
These are usually completely refractory to
FV, due to the presence ofthe FV2r gene,
and are also a "B-type" strain with regard
to their sensitivity to N- and B-tropic FV
(Pincus et al., 1971). Even so, they
developed late-onset leukaemia although
thymectomized as adults, treated with
ATS and injected with 104 ID50 N-tropic
FV. In one experiment, 5/7 C57BL mice
become leukaemic after 31-61 weeks, but
an intact group only given virus remained
healthy throughout the same 61 weeks.
Histologically, the leukaemias were nearly
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all typed as lymphoblastic/lymphocytic,
with a variety of stages present. One was
myeloid (chloroleukaemia), and all showed
some signs of red-cell activity. There was
also evidence in this particular group of
mice that thymectomy was not complete.
DISCUSSION
We have shown that the oncogenic
effects of MSV are enhanced by prior
treatment with silica. Brain haemorrhages
and pleural and peritoneal effusions,
which are primarily characteristic ofhigh-
titre MSV infection (Harvey & East, 1971)
occurred in silica-pretreated mice, but not
in those given virus, or silica alone. In
addition, larger tumours developed at the
site of injection, and spleen weights were
greater. Splenomegaly, which may be used
as a simple measurement of infection by
FV (Rowe & Brodsky, 1959) or MSV
(Hirsch & Harvey, 1969) is also caused by
infiltrating macrophages stimulated by
silica injected i.p. Despite the presence of
large numbers of additional macrophages,
however, it was easy to distinguish the
gross splenic erythroblastosis typical of
FV or MSV.
Such an apparent increase in virus
could be mediated by depression of the
immune system, and/or by provision of
new target cells. The former could affect
the efficient production ofantibody and/or
the killing of cells producing virus. Since
cell division is necessary for the replication
of the oncornaviruses (Temin, 1967) it is
not surprising that neither FV (Marcelletti
& Furmanski, 1979) nor MSV (Harvey &
Davies, unpublished) replicate in adult
macrophages. However, recent evidence
that macrophage precursor cells can be
infected with FV (Marcelletti & Furman-
ski, 1979) and our evidence that the
enlarged spleens of silica-treated mice are
engorged with macrophages suggests that
such precursors may well be suitable and
additional target cells for MSV.
In addition to the complex effects of
silica on the immune system in toto, there-
fore, the findings that macrophages (du
Buy, 1975) or their precursors may act as
target cells for certain viruses makes it
more difficult to define their precise role in
these circumstances. However, they re-
main a facet of the immune response
against oncogenesis, since spontaneous
regression of FV-induced malignancies is
prevented when macrophages are sup-
pressed or eliminated (Marcelletti &
Furmanski, 1978). Although suckling mice
may be protected by transfer of adult
peritoneal macrophages even from the
lethal effects of some viruses (Hirsch,
Zisman & Allison, 1970; Rager-Zisman &
Allison, 1973) suckling BALB/c mice were
not similarly protected from the oncogenic
effects of moderate titres of MSV; indeed
the converse was true. The slight enhance-
ment observed here is probably not due to
the provision of new target cells, since
adult macrophages are not suitable, and
spleen weights in macrophage-injected
mice remained normal. It should be borne
in mind, however, that there is some
evidence that protection may partly be
dependent on the strain of mouse used
(Marcelletti & Furmanski, 1978; Ceglowski
& Friedman, 1975) and in earlier work the
suckling mice were newborn rather than
11-12 days old as in our experiments.
Resistance to FV due to the FV-1 locus
operates at the cellular level and may be
overcome by high virus titres in vitro
(Hartley et al., 1970). However, the
susceptibility of newborn B-type mice to
N-tropic FV cannot simply be explained
on a weight/dose basis, since weight-
adjusted doses may still not be sufficient
toinfect adultmice (Harvey,unpublished).
Since, apartfrom theFV-1 allele, the same
genetic controls for MuLV are present in
both BALB/c and DBA/2 mice, one must
assume that they are responsible for the
developing resistance of B-type mice to
N-FV with age-possibly by reducing
virus titres to a threshold level at which
the FV-1 gene then operates. Moreover, if
virus levels are the sole factor determining
FV-1 resistance in vivo, then clearly ATS
treatment but not adult thymectomy or
silica pre-treatment is an efficient methodRESPONSES TO ONCOGENIC VIRUSES 585
of enabling virus levels to reach the
threshold. Alternatively, the ablation by
ATS of FV-1-induced resistance in vivo
could be by the induction of an endo-
genous B-tropic leukaemia virus which,
acting as helper for SFFV, would enable
the virus to spread.
The FV-2r locus of C57BL mice renders
them refractory to the spleen focus form-
ing virus (SFFV) component of the FV
complex (Axelrad, 1966; see review by
Lilly & Pincus, 1973) and, therefore, to
the usual rapid erythroproliferative re-
sponse to the virus. However, the lymph-
atic leukaemia virus (LLV) "helper"
component of FV is not controlled by the
FV-2 locus and does replicate, since
Steeves et al. (1971) have isolated an
active pathogenic LLV from FV-infected
C57 mice, although in their experiments
virus was obtained from mice which did
not show any overt signs ofleukaemia. We
have now shown that the early ATS treat-
ment of FV-infected C57:BL mice results,
after a considerable time lag, in the actual
oncogenic expression ofwhat we believe to
be the helper virus. The mechanism ofthe
long-term effects upon leukaemogenesis of
the early depression ofwhat are primarily
cell-mediated immune responses remains
to be determined.
Used as "controls" for ATS treatment,
the enhancing effect of "normal" serum
injections on oncogenic viruses has been
speculatively attributed to stimulation of
primitive precursor cells (Larson et al.,
1972) and to lymphopenia less pronounced
than that induced by ATS, but caused by
a similar mechanism (Hirsch & Murphy,
1968). Since we obtained clear evidence of
augmentation by saline injection, and to
some extent merely by subjecting the
mice to the procedure for the injections
with or without abdominal puncture, we
are confident that these effects are
primarily due to the lymphopenic (Golba
et al., 1974) immunosuppressive effects of
stress. There have been some apparently
conflicting reports concerning the results
of deliberately applied stress on various
forms of murine cancer (reviewed by La
Barba, 1970). Our own attempts to
examine the responses ofadrenalectomized
mice were frustrated, because the "con-
trols" did not behave as expected, and in
this particular case no evidence of viral
enhancement was apparent. In all 7
experiments before this using considerable
numbers of animals, there had been clear
enhancement of FV infection by saline or
other stress procedures. However, it is also
true that the majority of mice used were
male, and whilst the stress effect definitely
occurred in females, the results were less
consistent. This serves to emphasize that
the conditions in which the mice are kept
and handled, and many other variables,
considerably affect their response to
simple procedures. Riley (1975) has pub-
lished similar caveats about the large
effects of environmental stress on mice
infected with the mammary tumour virus.
Some ofthe comparatively severe methods
used deliberately to stress animals (Otis &
Scholler, 1967) may be unnecessary, and
even confuse matters. In any event, it
seems prudent in experiments with mice
that involve a two-stage procedure, to
consider the need for controls that would
allow the measurement of any element of
stress.
We thank Dr A. C. Allison, Dr J. East and Dr
D. A. J. Tyrrell for helpful advice. Miss M. Tuffrey
kindly performed the adrenalectomy operations.
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